Managed Account Advisors’s West Pharmaceutical WST Stock Holding History

Managed Account Advisors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$20.4M	Buy	351,416 +25,280	+8%	+$1.41M	0.02%	713
2015 Q1	$19.6M	Buy	326,136 +6,814	+2%	+$363K	0.02%	726
2014 Q4	$17M	Sell	319,322 -9,416	-3%	-$471K	0.02%	782
2014 Q3	$14.7M	Buy	328,738 +84,173	+34%	+$3.58M	0.02%	825
2014 Q2	$10.3M	Buy	244,565 +6,495	+3%	+$278K	0.01%	1004
2014 Q1	$10.5M	Sell	238,070 -28,721	-11%	-$1.35M	0.01%	943
2013 Q4	$13.1M	Buy	266,791 +34,858	+15%	+$1.63M	0.02%	829
2013 Q3	$9.54M	Sell	231,933 -17,511	-7%	-$668K	0.01%	931
2013 Q2	$8.76M	Buy	+249,444	New	+$8.21M	0.01%	932

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Managed Account Advisors's WST Position: Q2 2015 in Review

Managed Account Advisors increased its West Pharmaceutical (WST) stake by 7.8% in Q2 2015, buying an estimated $1.41M and bringing the position to 351,416 shares worth $20.4M. The position accounts for 0.02% of the portfolio, ranked #713.

Managed Account Advisors first reported a position in WST in Q2 2013 and has held it in 9 quarters since. 219 funds tracked by Wall St. Rank hold WST as of Q2 2015.

Managed Account Advisors held 351,416 shares of West Pharmaceutical worth $20.4M as of Q2 2015.
Managed Account Advisors bought 25,280 West Pharmaceutical shares in Q2 2015, an estimated $1.41M.
West Pharmaceutical made up 0.02% of Managed Account Advisors's portfolio in Q2 2015, its #713 holding.
Managed Account Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 9 quarters since.
219 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.